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Abstract
Background:  Low levels of uracil in DNA result from misincorporation of dUMP or cytosine
deamination. Vaccinia virus (VACV), the prototype poxvirus, encodes two enzymes that can potentially
reduce the amount of uracil in DNA. Deoxyuridine triphosphatase (dUTPase) hydrolyzes dUTP,
generating dUMP for biosynthesis of thymidine nucleotides while decreasing the availability of dUTP for
misincorporation; uracil DNA glycosylase (UNG) cleaves uracil N-glycosylic bonds in DNA initiating base
excision repair. Studies with actively dividing cells showed that the VACV UNG protein is required for
DNA replication but the UNG catalytic site is not, whereas the dUTPase gene can be deleted without
impairing virus replication. Recombinant VACV with an UNG catalytic site mutation was attenuated in vivo,
while a dUTPase deletion mutant was not. However, the importance of the two enzymes for replication
in quiescent cells, their possible synergy and roles in virulence have not been fully assessed.
Results: VACV mutants lacking the gene encoding dUTPase or with catalytic site mutations in UNG and
double UNG/dUTPase mutants were constructed. Replication of UNG and UNG/dUTPase mutants were
slightly reduced compared to wild type or the dUTPase mutant in actively dividing cells. Viral DNA
replication was reduced about one-third under these conditions. After high multiplicity infection of
quiescent fibroblasts, yields of wild type and mutant viruses were decreased by 2-logs with relative
differences similar to those observed in active fibroblasts. However, under low multiplicity multi-step
growth conditions in quiescent fibroblasts, replication of the dUTPase/UNG mutant was delayed and 5-
fold lower than that of either single mutant or parental virus. This difference was exacerbated by 1-day
serial passages on quiescent fibroblasts, resulting in 2- to 3-logs lower titer of the double mutant compared
to the parental and single mutant viruses. Each mutant was more attenuated than a revertant virus upon
intranasal infection of mice.
Conclusion: VACV UNG and dUTPase activities are more important for replication in quiescent cells,
which have low levels of endogenous UNG and dUTPase, than in more metabolically active cells and the
loss of both is more detrimental than either alone. Both UNG and dUTPase activities are required for full
virulence in mice.
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Background
Uracil, a major component of RNA, is a rare constituent of
DNA due to misincorporation of dUMP from dUTP or the
spontaneous deamination of cytosine residues [1]. The
presence of uracil in DNA can have adverse effects. U:A
pairs arising from misincorporation are not mutagenic per
se since they can be corrected in the next round of replica-
tion. However, U:G mispairs arising from deamination
would lead to transition mutations. Free-living organisms
as well as some viruses encode uracil DNA glycosylase
(UNG) and deoxyuridine 5'-triphosphate (dUTPase),
which may lower the amount of uracil in DNA [2,3]. By
hydrolyzing dUTP, dUTPase generates dUMP for the bio-
synthesis of thymidine nucleotides while concurrently
decreasing the availability of dUTP for misincorporation
[4]. UNG specifically recognizes uracil in DNA and initi-
ates base excision repair by hydrolyzing the glycosylic
bond linking uracil to a deoxyribose sugar. An abasic site
is created that is removed by a 5'-acting apurinic/apyri-
midic endonuclease and a DNase, leaving a gap filled by
DNA polymerase and sealed by ligase [5].
Viruses that encode UNG or dUTPase include poxviruses,
herpesviruses, African swine fever virus and some retrovi-
ruses [3]. Poxviruses are large, complex viruses that reside
exclusively in the cytoplasm of host cells and encode DNA
polymerase and other enzymes and factors necessary to
replicate their double-stranded DNA genomes [6,7]. All
sequenced members of the chordopoxvirus subfamily
encode an UNG [8-10]. Because cellular UNGs have a
repair function that is unnecessary for viability, it was sur-
prising that vaccinia virus (VACV) UNG encoded by the
D4R (VACV-WR-109) open reading frame is essential for
DNA replication [10,11]. Subsequent mutagenesis stud-
ies, however, showed that the critical role of D4 (the pro-
tein encoded by D4R) is independent of its DNA
glycosylase activity, though the latter is required for full
virulence in a mouse intranasal infection model [12]. D4
has a direct role in replication as it is complexed with
other viral replication proteins and increases the proces-
sivity of the DNA polymerase [13-16]. Many poxviruses,
including variola virus and VACV, encode a dUTPase as
well as an UNG [17]. In contrast to UNG, however, the
dUTPase encoded by the VACV F2L (VACV-WR-041) open
reading frame was deleted without affecting viral replica-
tion in cell culture or virulence in a mouse infection
model, although hypersensitivity to the drug (N)-meth-
anocarbathymidine suggests that pyrimidine metabolism
is altered in infected cells [18,19]. African swine fever
virus, distantly related to poxviruses, encodes a dUTPase
that is dispensable for replication in dividing Vero cells
but is required for efficient replication in non-dividing
swine macrophages [20].
Herpesviruses are large, DNA viruses that replicate in the
nucleus and encode UNG and dUTPase as well as DNA
polymerase [21-23]. The UNG proteins encoded by her-
pes simplex virus type 1 (HSV-1) and varicella zoster virus
are dispensable for replication in cultured cells [22,24],
but are required for efficient HSV-1 replication and latent
infection in the murine nervous system [25]. Deletion of
the cytomegalovirus UNG caused a delay in viral DNA
replication in quiescent human fibroblasts [26,27]. It was
suggested that UNG creates sites in cytomegalovirus DNA
that are used for recombination-dependent replication
late in infection. HSV-1 dUTPase is also dispensable for
replication in actively growing cultured cells but is
required for full neurovirulence in a mouse model
[25,28].
Although retroviruses do not encode UNG, HIV-1 pack-
ages a cellular UNG that is essential for its life cycle [29-
31]. Interestingly, the packaging of a heterologous UTPase
can complement the defect associated with the absence of
HIV-1 virion-associated UNG [31]. β-retroviruses and
non-primate lentiviruses encode a dUTPase that is impor-
tant for replication in non-dividing macrophages and
inducing disease [32-35].
Taking together the results from a variety of systems, it
seems that the requirements for virus-encoded UNG and
dUTPase are greatest in quiescent cells [3], which have low
endogenous UNG and dUTPase levels [36,37] and rela-
tively high ratios of dUTP to dTTP [38,39]. In addition, we
considered that there might be a greater need for UNG if
dUTP levels increased in the absence of dUTPase. For the
present study, we compared the replication of single and
double VACV dUTPase deletion and UNG catalytic site
mutants in actively growing and quiescent cells as well as
the virulence of the mutants in a mouse respiratory infec-
tion model.
Results
Construction of single and double VACV UNG and 
dUTPase mutants
The VACV D4R catalytic site mutant with Asp-68-Asn and
His-181-Leu changes and containing an enhanced green
fluorescent protein (GFP) reporter gene was previously
constructed and shown to lack DNA glycosylase activity
[12]. This D4R catalytic site mutant will be referred to here
as vd4. The F2L gene was deleted from both wild type
VACV WR (referred to subsequently as WR) and from vd4
by recombination with a plasmid containing red fluores-
cent protein (RFP) flanked by F1L and F3L DNA to form
vΔF2 and vΔF2d4, respectively (Fig. 1A). WR and vΔF2
plaques on BS-C-1 cells were indistinguishable, whereas
those of vd4 and vΔF2d4 were slightly smaller (Fig. 1B) as
had been noted previously for vd4 [12]. Thus, deletion ofVirology Journal 2008, 5:145 http://www.virologyj.com/content/5/1/145
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the F2L gene did not alter the plaque size of WR or further
reduce the plaque size of vd4.
Replication of mutated viruses and DNA in actively 
dividing BS-C-1 cells
Our previous study showed that vd4 yielded slightly lower
titers than WR in RK13 cells under one-step growth condi-
tions and this correlated with slightly lower levels of DNA
synthesis [12]. Here, we compared the replication kinetics
of the D4 and F2 single and double mutant viruses in BS-
C-1 cells. The 24 h titers were consistently WR > ΔF2 > vd4
~ΔF2d4, though the differences were very small (Fig. 2A).
To measure viral DNA synthesis, BS-C-1 cells were
infected with WR or mutant viruses at a multiplicity of 5
plaque-forming units (PFU) per cell. At various times,
infected cells were harvested and total DNA was isolated.
Viral DNA accumulation was quantified by hybridization
to a 32P-labeled VACV DNA probe. The kinetics of vd4 and
vΔF2d4 DNA replication were virtually identical and the
amounts of DNA were about one-third lower than VACV
WR at 24 h (Fig. 2B). In contrast, vΔF2 DNA synthesis was
close to that of WR at all time points (Fig. 2B).
Replication of mutated viruses in active and resting human 
foreskin fibroblasts (HFF)
The relatively modest effect of the UNG and dUTPase
mutations could be a consequence of the presence of the
corresponding cellular enzymes in actively replicating
cells. Therefore, we compared the replication of the
mutated viruses in actively growing HFF propagated in
10% fetal bovine serum (FBS) or in stationary cells that
had been incubated for 4 days in 0.2% FBS. Active and
quiescent HFF were infected with WR or mutant viruses at
a multiplicity of 5 and harvested at sequential times. As
with BS-C-1 cells, vd4 and vΔF2d4 replicated to slightly
lower titers than WR and vΔF2 in active HFF (Fig. 3). In
quiescent HFF, the recoveries of input viruses at 1 h were
approximately 1 log less than for the active HFF, suggest-
ing reduced virus attachment (Fig. 3). Virus titers slowly
increased between 6 and 24 h but were still about 2-logs
less than in the metabolically active cells (Fig. 3). Never-
theless, by 12 h most cells appeared to be expressing fluo-
rescent protein, although less brightly than in active cells.
The relative differences in yields between VACV and
mutant viruses were similar in resting and active cells.
Phenotypic differences between mutant viruses can be
more pronounced when cells are infected at a low multi-
plicity, in which virus spread is also assessed. Therefore,
we infected HFF at a multiplicity of 0.001 and measured
virus replication over a 6-day period. At one day after
infection of active HFF, the relative titers were WR > vΔF2
> vd4 > vΔF2d4 (Fig. 4A). In each case the virus titers
increased by day 2 but then reached a plateau and
decreased. By days 5 and 6, the titers of the different
viruses were similar (Fig. 4A). In the quiescent cells, virus
titers increased for 4 to 5 days and except for vΔF2d4 even-
tually reached titers similar to the final titers in the actively
growing cells (Fig. 4B). On days 2 and 6, the titers of
vΔF2d4 were 25- and 5.5-fold lower, respectively, than
WR. All infected monolayers, except those inoculated with
vΔF2d4, showed extensive cytopathic effects by day 5.
VACV expresses a growth factor called VGF that is secreted
from infected cells and is important for replication in rest-
ing cells [40]. Therefore, secreted VGF may have stimu-
lated the metabolism of the HFF cells in low serum over
time contributing to the ability of vΔF2d4 to partly catch
up to WR. To reduce this effect, we developed a protocol
Construction and plaque formation of VACV mutants with  deletion of the dUTPase gene and active site mutations in the  uracil DNA glycosylase gene Figure 1
Construction and plaque formation of VACV 
mutants with deletion of the dUTPase gene and 
active site mutations in the uracil DNA glycosylase 
gene. (A) Schematic diagram of the VACV genome organiza-
tion. The WR genome is represented with expansions show-
ing replacement of F2L gene with RFP in vΔF2 and vΔF2d4 
and D68N and H181L point mutations (indicated by aster-
isks) in D4R gene with adjacent green fluorescent protein 
gene in vd4 and vΔF2d4. (B) Plaques of WR, vd4, vΔF2, and 
vΔF2d4 on BS-C-1 cells. Viruses were plated on BS-C-1 cell 
monolayers and covered with a semi-solid methylcellulose 
overlay. After 2 days at 37°C, the monolayers were stained 
with crystal violet.Virology Journal 2008, 5:145 http://www.virologyj.com/content/5/1/145
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in which active and quiescent HFF were initially infected
at a multiplicity of 5. Then, each day the cells were har-
vested, washed, resuspended in fresh medium, lysed and
10% used to inoculate new active or quiescent cells. In
addition, we wanted to rule out the possibility that the
replication of vΔF2d4 was in some way compromised by
the expression of both GFP and RFP. Therefore, a new
recombinant virus vΔF2d4(-FP) was made by sequentially
deleting the two reporter genes from vΔF2d4. The titers of
vΔF2d4 and vΔF2d4(-FP) decreased by 2- to 3-logs over a
period of 7 passages in the resting cells (Fig. 5A), whereas
the titers were maintained in actively growing cells (Fig.
5B). The vd4 and vΔF2 titers were only slightly less than
those of WR, with a maximum 2.2-fold difference.
Mutant viruses are less pathogenic than wild-type virus
We had previously reported that vd4 was attenuated com-
pared to WR in a murine intranasal infection model [12].
Here we compared the virulence of vd4 to vΔF2 and
vΔF2d4. As an additional control to rule out a spontane-
ous mutation affecting virulence that might have occurred
elsewhere in the genome during the construction of the
recombinant viruses, we made a revertant virus vΔF2d4rev
in which the dUTPase gene and the unmutated UNG gene
of vΔF2d4 were restored with the simultaneous deletion
of the two fluorescent reporter genes. vΔF2d4rev formed
normal size plaques and replicated like wild type virus
(data not shown).
Groups of Balb/c mice were infected intranasally with 104
to 106 PFU of each virus and loss of weight was followed
for two weeks. All animals in the WR and revertant groups
that had been infected with 105 or 106 PFU died or were
terminated by day 6 because their weights dropped by
30% (Fig. 6A, B, G, H). Of the mice infected with 104 PFU
of WR or revertant, one and four animals survived, respec-
tively, consistent with the LD50 of approximately 104.
Mice infected with vΔF2 did better; although those inocu-
lated with 106 PFU died, all inoculated with 104 or 105
PFU survived for at least 10 days and the majority for 14
days (Fig. 6C, I). Mice infected with vd4, vΔF2d4, or
vΔF2d4(-FP) did still better as all survived infections with
104 and 105 PFU and some even survived 106 PFU (Fig.
6D–F, J–L). The statistical significance of the differences in
weight loss on day 5, prior to any deaths, was determined
(Table 1). The difference between the revertant virus and
each of the mutants was significant, whereas the differ-
ences between mutants were mostly not significant.
Discussion
The molecular structures and catalytic activities of VACV
UNG and dUTPase have been well characterized [9,17,41-
Virus replication and DNA synthesis in BS-C-1 cells Figure 2
Virus replication and DNA synthesis in BS-C-1 cells. Confluent 6 well plates of BS-C-1 cells were infected with WR and 
recombinant viruses at a multiplicity of 5. The infected cells were harvested at the indicated hours post infection (hpi) to deter-
mine virus titers and viral DNA. (A) Virus titers were determined on BS-C-1 cells and plotted as PFU/ml. All experiments were 
carried out in triplicate. Average titers are shown; bars representing standard error of the mean could not be printed because 
of their very close spacing. (B) Viral DNA was determined by blot hybridization and quantified with a phosphorImager. Experi-
ment represents average of duplicate experiments.Virology Journal 2008, 5:145 http://www.virologyj.com/content/5/1/145
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44], but less is known about their roles in virus replica-
tion. Indeed, the conservation of these enzymes in poxvi-
ruses contrasted with the apparent unimportance of the
virus encoded UNG and dUTPase activities for replication
in tissue culture cells [12,19]. These observations were
confirmed in the present study where we found that even
double mutants with a catalytic site mutation in UNG and
deletion of dUTPase exhibited only a small defect in rep-
lication in actively growing tissue culture cells. However,
active cells have higher endogenous levels of dUTPase and
UNG [36,37] and lower levels of dUTP [38,39] than rest-
ing cells. Presumably for this reason, other viruses with
dUTPase or UNG deletions have a more debilitated phe-
notype in resting cells than active cells [3,26,27]. In the
present study, we found that mutation of VACV dUTPase
or UNG had a relatively small growth effect in quiescent
human fibroblasts but that mutation of both caused a
large decrease in replication.
Previous studies had shown that VACV replicates more
poorly in resting mouse 3T3 cells than actively growing
cells and this was most severe in low multiplicity, multi-
cycle infections with a mutant virus unable to express the
secreted growth factor VGF [40]. With wild type virus,
secreted VGF could activate resting cells prior to the next
round of infection. The restriction in resting 3T3 cells was
not determined, although it appeared to be mainly a post-
entry phenomenon. In contrast, wild type VACV is unable
to bind to and enter resting T lymphocytes [45]. For the
present study we used stationary cultures of primary
human fibroblasts that were maintained for four days in
low serum. Under one-cycle growth conditions, the 24 h
yields of virus were wild-type > dUTPase mutant > UNG
mutant > double mutant with about 1/2 log difference
between the highest and lowest. However, even the wild
type VACV titers were about a log lower in quiescent com-
pared to active fibroblasts. This general effect appeared to
be partly due to decreased binding since the difference
was seen in the first time points prior to replication. How-
ever, this was only part of the story since most cells were
infected by 12 h. The disparity between the replication of
the double mutant and the other mutants and wild type
virus was more marked under low multiplicity, multicycle
infection conditions. On day two, the difference was
about 25-fold but only 5-fold on day six. We considered
that the mutant might be catching up with time because
of the secretion of VGF. Therefore, we altered the protocol
so that each day the cells were harvested and a new culture
of cells were inoculated. Under these conditions, the dif-
ference in resting cells between the double mutant and
parental virus was 2 – 3 logs by day seven. In contrast, the
difference between the single mutants and parental virus
was only 2-fold.
In quiescent cells, the impairment caused by deletion of
the dUTPase gene could have resulted from decreased
availability of dUMP for biosynthesis of thymidine nucle-
otides or from misincorporation of uracil nucleotides due
to increased amounts of dUTP. The impairment caused by
mutation of UNG, could have resulted from the failure to
excise uracil and resulting transition mutations. However,
we could not confirm the presence of excess uracil in DNA
purified from dUTPase/UNG double mutants. Following
treatment with UNG, we found 44 and 38 apurinic sites
per 100,000 base pairs in parental and mutant DNA,
respectively (FDS, unpublished data). The possibility of
an increased mutation rate needs to be investigated.
The intranasal mouse model has been extensively used to
determine virulence of mutant VACV and morbidity and
death results primarily from the respiratory infection [46-
51]. We reproduced our previous finding that the VACV
UNG catalytic site mutant was attenuated in this model
[12]. In addition, we found that mice inoculated with the
dUTPase mutant or the double mutant lost less weight
and survived higher doses of virus than those inoculated
with a revertant virus. However, we did not find a statisti-
cally significant difference in the attenuation of the single
and double mutants. In contrast to our results, Prichard
and coworkers [19] did not find that a VACV dUTPase
deletion mutant was attenuated. The difference might be
One-step virus growth in metabolically active and quiescent  HFF Figure 3
One-step virus growth in metabolically active and 
quiescent HFF. Confluent 6-well plates of active (open 
symbols) and quiescent (closed symbols) HFF were infected 
with WR and recombinant viruses at a multiplicity of 5. The 
infected cells were harvested at the indicated times post 
infection and virus titers were determined on BS-C-1 cells. 
Average titers are shown; bars representing standard error 
of the mean could not be printed because of their very close 
spacing.Virology Journal 2008, 5:145 http://www.virologyj.com/content/5/1/145
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Low multiplicity virus infection and spread in active and quiescent HFF Figure 4
Low multiplicity virus infection and spread in active and quiescent HFF. Confluent 6 well plates of active (A) and qui-
escent (B) HFF were infected with viruses at a multiplicity of 0.001. Every 24 h triplicate wells were harvested and titered on 
BS-C-1 cells. Average titers are shown. Error bars represent the standard error of the mean.Virology Journal 2008, 5:145 http://www.virologyj.com/content/5/1/145
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due to the greater susceptibility to VACV infection of the
3-week old mice used in the previous study compared to
the 6-week old mice used here. It would be interesting to
examine other routes of virus inoculation since the repli-
cation of the mutant viruses may be cell type dependent.
Conclusion
VACV recombinants with mutations in the catalytic site of
UNG and/or a deletion of the dUTPase gene were con-
structed. In actively growing cells, the UNG mutant and
the double mutant exhibited a slight reduction in replica-
tion, whereas replication of the single dUTPase deletion
mutant was unimpaired. However, in quiescent human
fibroblasts, which have low levels of endogenous UNG
and dUTPase, replication of the double mutant was more
severely inhibited than either of the single mutants.
Expression of viral UNG and dUTPase were required for
full virulence in mice.
Serial virus passage in active and quiescent HFF Figure 5
Serial virus passage in active and quiescent HFF. Quiescent (A) and active (B) HFF were infected with 5 PFU per cell of 
WR or indicated mutant virus. After 24 h, the cells were harvested and 10% of the lysate used to infect fresh quiescent or 
active HFF. The procedure was repeated for a total of 7 serial infections. Experiments were carried out in triplicate. Average 
titers are shown and bars represent the standard error of the mean.Virology Journal 2008, 5:145 http://www.virologyj.com/content/5/1/145
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Weight loss and lethality following intranasal infections Figure 6
Weight loss and lethality following intranasal infections. Six-week female BALB/c mice were infected intranasally with 
104-106 PFU of purified WR or mutant or revertant (Rev) viruses. Mice were weighed daily and animals that lost ≥ 30% of their 
original weight were terminated. The % average weight of each group at the indicated times was plotted (A-F). Graphs repre-
sent mean of experiment (n = 5 mice/group) and bars represent the standard error of the mean. (G-L) The % of surviving mice 
at each time was plotted.Virology Journal 2008, 5:145 http://www.virologyj.com/content/5/1/145
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Table 1: Statistical significance of weight loss between infected groups of mice
Comparison Titer Day No. mice P-value P < 0.05
vΔF2d4rev versus vΔF2 104 5 5 0.0079 Yes
105 5 5 0.0079 Yes
106 5 5 0.8413 No
vΔF2d4rev versus vd4 104 5 5 0.0079 Yes
105 5 5 0.0079 Yes
106 5 5 0.6905 No
vΔF2d4rev versus vΔF2d4 104 5 5 0.0317 Yes
105 5 5 0.0079 Yes
106 5 5 0.0079 Yes
vΔF2d4rev versus vΔF2d4(-FP) 104 5 5 0.0079 Yes
105 5 5 0.0079 Yes
106 5 5 0.0952 No
vΔF2 versus vd4 104 5 5 0.0952 No
105 5 5 0.1508 No
106 5 5 0.5476 No
vΔF2 versus vΔF2d4 104 5 5 0.3095 No
105 5 5 0.0556 No
106 5 5 0.0079 Yes
vΔF2 versus vΔF2d4(-FP) 104 5 5 0.3095 No
105 5 5 0.8413 No
106 5 5 0.1508 No
vd4 versus vΔF2d4 104 5 5 0.5476 No
105 5 5 0.5476 No
106 5 5 0.1508 No
vd4 versus vΔF2d4(-FP) 104 5 5 0.1508 No
105 5 5 0.0317 Yes
106 5 5 0.8413 No
P values of all surviving mice (n = 5) on day 5 at specific viral titers were calculated based on the Mann-Whitney Test (non-parametric, two-tailed, 
and 95% confidence intervals) with P < 0.05 considered significant.Virology Journal 2008, 5:145 http://www.virologyj.com/content/5/1/145
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Methods
Cells, virus, and plasmids
HFF were obtained from A. McBride (NIAID, NIH,
Bethesda, MD). Monolayer cultures of HeLa S3, HFF and
BS-C-1 cells were maintained in Eagle's minimal essential
medium (EMEM; Quality Biologicals, Inc, Gaithersburg,
MD) containing L-glutamine and 10% FBS. All experi-
ments were performed with the WR strain of VACV (ATCC
VR-1354) or with mutant viruses derived from this strain.
The VACV D4R catalytic site mutant containing Asp-68-
Asn and His-181-Leu changes was previously described
[12]. Plasmid pUC19slp containing a VACV synthetic late
promoter was provided by C. Ansarah-Sobrinho (NIAID,
NIH, Bethesda, MD). Plasmid pslpRed was created by
cloning the RFP open reading frame by PCR using Accu-
prime pfx (Invitrogen, Carlsbad, CA) and primers 5'-
ACCATGGTGAGCGGCCTGCTGAAGGAG-3' and 5'-
TTAGTTGGCCTTCTCGGGCAGGTCGCTGTA-3', then
digesting the PCR product with Sal I/BamH I followed by
ligation of the digested product between the Sal I/BamH I
sites of pUC19slp. Plasmid pΔF2 containing RFP flanked
by F1 and F3 sequences was constructed as follows: DNA
containing the F1L and 76 nucleotides of F2L was
obtained by PCR using Accuprime pfx and primers 5'-
CCGGAATTCCTTACACCCAACCCCTTGTTATCCA-3' and
5'-CCGGAATTCTCCAGAACTGGAAGAAGTACAATCTCT-
3'.
The PCR product was inserted into an EcoR I site upstream
of the RFP gene. A segment of DNA containing F3L and 74
nucleotides of F2L using Accuprime pfx and primers 5'-
AAAACTGCAGATGCTGCTTGGGTTAATATGCCGAGT-3'
and 5'-CGCGGATCCTGCCTAGTAGGAGATTTAGCTC
TGT-3' was amplified by PCR. The PCR product was
inserted between BamH I and Pst I sites downstream of
the RFP gene. The general procedures used for preparing
and titrating the viral stocks were described previously
[52].
Construction of VACV F2L deletion and D4R catalytic site 
mutants
Approximately 106 BS-C-1 cells were infected with WR or
vd4 at a multiplicity of 0.05 PFU per cell for 1 h at 37°C.
The infected cells were washed twice with Opti-MEM (Inv-
itrogen) and transfected with 2 μg of pΔF2. After 5 h, the
transfection mixture was replaced with EMEM/2.5% FBS,
and the cells were harvested at 48 h in 0.5 ml of EMEM/
2.5% FBS. Lysates were prepared by freezing and thawing
the cells three times and sonicating them twice for 30 s.
Recombinant viruses that expressed RFP (vΔF2) or both
RFP and GFP (vΔF2d4) were plaque purified five times on
BS-C-1 cells and their genetic purity was confirmed by
PCR, Southern blotting, and sequencing.
To construct recombinant vΔF2d4 (-FP) lacking both GFP
and RFP genes, PCR products were made by overlapping
PCR that had (i) F1 and F3 sequences but missing the F2L
ORF and (ii) D4 and D5 sequences that maintained the
catalytic site mutations mutations of D4. 
F1r: 5'-CCGCTCGAGCGGTTACACCCAACCCCTTGTTAT
CCATTAG-3', 
F1f: 5'-CTAACAGAGCTAAATCTCCTACTATCCAGAACT-
GGAAGAAGTACAATCTCTA-3', 
F3r: 5'-TTGTACTTCTTCCAGTTCTGGATAGTAGGAGATT-
TAGCTCTGTTAGTTTCC-3', 
F3f: 5'-CCCAAGCTTGGGATGCTGCTTGGGTTAATATGC
CGAGTC-3', 
D4f: 5'-CCGCTCGAGCGGATGAATTCAGTGACTGTATC
ACACGCGCC-3', 
D4r: 5'-TTAGAACACAAGTTAAAATTTCACTAAAGGTTAA
TAAATAAACCCTTGAGCCCAATTTAT-3',
D5f: 5'-CTTTAGTGAAATTTTAACTTGTGTTCTAAATGGA
TGCGGCTATTAGAGGTAATGATG-3', 
D5r: 5'-CCCAAGCTTGGGTTTCTCCTATATACGGCAGTG
TCTATCG-3'. 
The procedure for making recombinants was the same as
above, except vΔF2d4 was used to infect BS-C-1 cells and
virus that lacked RFP was first selected (i.e. only green flu-
orescence) followed by virus that lacked RFP and GFP (no
fluorescence).
To construct a revertant that has wild type F2L and D4R
sequences without RFP and GFP, PCR products were
made that had (i) F1-F2-F3 sequences and (ii) D4-D5
sequences from WR. Primers F1r and F3f were used to
amplify DNA from WR. Primers P1: 5'-CGAGTATGTGT-
GTGTGGTATAGATCC-3' and P2: 5'-CGGCAGTGTC-
TATCGATCTTGTTAGTG-3' were used to amplify DNA
from WR. Virus was constructed as above using vΔF2d4
and virus that lacked RFP was first selected (i.e. only green
fluorescence) followed by virus that lacked RFP and GFP
(no fluorescence).
One-step virus growth
For one step virus growth, confluent BS-C-1 or HFF in six-
well plates were infected with 5 PFU of virus per cell and
maintained at 37°C for 1 h. The innocula were removed,
cells washed three times, and overlaid with 2 ml of
EMEM/2.5% FBS. The cells were maintained at 37°C andVirology Journal 2008, 5:145 http://www.virologyj.com/content/5/1/145
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harvested at various times after infection, collected by cen-
trifugation, and resuspended in EMEM/2.5% FBS. The
cells were disrupted by three cycles of freezing and thaw-
ing and two 30-s bursts of sonication. Virus yields were
determined by titration on BS-C-1 cells.
Detection of viral DNA by slot blot hybridization
Confluent BS-C-1 cells in six-well plates were infected
with 5 PFU of virus per cell. The cells were collected by
centrifugation, washed once with phosphate-buffered
saline, and re-suspended in 0.3 ml of 1.5 M NaCl-0.15 M
sodium citrate (pH 7.0)-1 M ammonium acetate. The cells
were disrupted by three cycles of freezing and thawing.
After dispersal by vortexing, duplicate 50 μl samples were
spotted onto an Immobilon-Ny+ transfer membrane in a
slot blot apparatus. The membrane was treated sequen-
tially with 0.5 M NaOH-1 M Tris-HCl (pH 7.5) and 0.3 M
NaCl-0.03 M sodium citrate (pH 7.0) and cross-linked by
UV irradiation. The membrane was air dried, and viral
DNA was detected by hybridization using a radiolabeled
probe generated by random priming using VACV I7 gene
nucleotide sequences, Random labeling kit (Invitrogen,
Carlsbad, CA) and [α-32P]dCTP (PerkinElmer, Shelton,
CT). The blot was exposed to a phosphor screen, and data
were acquired on a Storm PhosphorImager (Molecular
Dynamics, Sunnyvale, CA) and quantified with Image-
Quant software (Molecular Dynamics).
Infection of active and quiescent HFF
HFF were seeded into 6 well tissue culture plates in
EMEM/10% FBS. When monolayers were confluent, the
culture medium was replaced with EMEM/0.2% FBS and
maintained under these conditions for 96 h to induce qui-
escence. Following this treatment, HFF were infected with
recombinant virus in EMEM/0.2% FBS. Alternatively, cells
were propagated in EMEM/10% FBS and as soon as con-
fluent the active cell monolayers were infected with
recombinant virus in EMEM/2.5% FBS. At the indicated
times post infection, infected monolayers were harvested
and resuspended in EMEM/2.5% FBS. The cells were dis-
rupted by three cycles of freezing and thawing and two 30-
s bursts of sonication. Virus yields were determined by
titration on BS-C-1 cells.
Animal studies
Purified virus for animal studies were obtained as follows.
HeLa cells (2.5 × 108) were infected with 3 PFU of virus
per cell and harvested three days after infection. Cells were
re-suspended in 10 mM Tris (pH 9.0) and Dounce
homogenized. The cytoplasm was separated from nuclei
by low speed centrifugation and layered on a 36% sucrose
cushion. After centrifugation at 13,500 rev/min in a SW
28.1 rotor for 80 min at 4°C, the viral pellet was sus-
pended in 10 mM Tris (pH 9.0) and the virus titer deter-
mined by plaque assay. Groups (n = 5) of 6-week-old,
female BALB/c mice were anesthetized and inoculated
intranasally with 104-106 PFU of virus in 20 μl (half in
each nostril). Each mouse was weighed daily and animals
that lost 30% of their original body weight were termi-
nated according to a protocol approved by the NIAID Ani-
mal Care and Use Committee.
Statistical Methods
Significance was determined with the Mann-Whitney test
(non-parametric, two-tailed, and 95% confidence) using
Prism (Graphpad Software, La Jolla, Ca).
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